Gomberg-Maitland M - Search Results

1

Phase I safety study of ranolazine in pulmonary arterial hypertension.

Gomberg-Maitland M, Schilz R, Mediratta A, Addetia K, Coslet S, Thomeas V, Gillies H, Oudiz RJ. Gomberg-Maitland M, et al. Pulm Circ. 2015 Dec;5(4):691-700. doi: 10.1086/683813. Pulm Circ. 2015. PMID: 26697176 Free PMC article.

2

Relative adrenal insufficiency in severe congestive heart failure with preserved systolic function: a case report.

Lovelock JD, Coslet S, Johnson M, Rich S, Gomberg-Maitland M. Lovelock JD, et al. J Cardiovasc Med (Hagerstown). 2007 Sep;8(9):754-7. doi: 10.2459/JCM.0b013e328011c256. J Cardiovasc Med (Hagerstown). 2007. PMID: 17700413

3

Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension.

Shah SJ, Thenappan T, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Shah SJ, et al. Circulation. 2008 May 13;117(19):2475-83. doi: 10.1161/CIRCULATIONAHA.107.719500. Epub 2008 May 5. Circulation. 2008. PMID: 18458173

4

Tadalafil therapy for pulmonary arterial hypertension.

Galiè N, Brundage BH, Ghofrani HA, Oudiz RJ, Simonneau G, Safdar Z, Shapiro S, White RJ, Chan M, Beardsworth A, Frumkin L, Barst RJ; Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group. Galiè N, et al. Circulation. 2009 Jun 9;119(22):2894-903. doi: 10.1161/CIRCULATIONAHA.108.839274. Epub 2009 May 26. Circulation. 2009. PMID: 19470885 Clinical Trial.

5

A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension.

Gomberg-Maitland M, Maitland ML, Barst RJ, Sugeng L, Coslet S, Perrino TJ, Bond L, Lacouture ME, Archer SL, Ratain MJ. Gomberg-Maitland M, et al. Clin Pharmacol Ther. 2010 Mar;87(3):303-10. doi: 10.1038/clpt.2009.217. Epub 2009 Dec 9. Clin Pharmacol Ther. 2010. PMID: 20010555 Free PMC article. Clinical Trial.

6

Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective.

Gomberg-Maitland M, Dufton C, Oudiz RJ, Benza RL. Gomberg-Maitland M, et al. J Am Coll Cardiol. 2011 Mar 1;57(9):1053-61. doi: 10.1016/j.jacc.2010.11.020. J Am Coll Cardiol. 2011. PMID: 21349396 Free article. Review.

7

Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction.

Thenappan T, Shah SJ, Gomberg-Maitland M, Collander B, Vallakati A, Shroff P, Rich S. Thenappan T, et al. Circ Heart Fail. 2011 May;4(3):257-65. doi: 10.1161/CIRCHEARTFAILURE.110.958801. Epub 2011 Mar 16. Circ Heart Fail. 2011. PMID: 21411741

8

The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension.

Rich JD, Glassner C, Wade M, Coslet S, Arneson C, Doran A, Gomberg-Maitland M. Rich JD, et al. Chest. 2012 Jan;141(1):36-42. doi: 10.1378/chest.11-0245. Epub 2011 Jun 9. Chest. 2012. PMID: 21659437

9

Risk assessment in pulmonary hypertension associated with heart failure and preserved ejection fraction.

Agarwal R, Shah SJ, Foreman AJ, Glassner C, Bartolome SD, Safdar Z, Coslet SL, Anderson AS, Gomberg-Maitland M. Agarwal R, et al. J Heart Lung Transplant. 2012 May;31(5):467-77. doi: 10.1016/j.healun.2011.11.017. Epub 2012 Jan 4. J Heart Lung Transplant. 2012. PMID: 22221678

10

Takotsubo cardiomyopathy after treatment of pulmonary arterial hypertension.

Cork DP, Mehrotra AK, Gomberg-Maitland M. Cork DP, et al. Pulm Circ. 2012 Jul;2(3):390-4. doi: 10.4103/2045-8932.101659. Pulm Circ. 2012. PMID: 23130109 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters